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infections, increased need for oxygen, and prolonged immobility,
place the patient at even greater risk. The Duke Pediatric Bone
Marrow/Stem Cell Transplant Program and the Division of Pedi-
atric Oncology developed a program in 2001 to minimize the
morbidity and mortality associated with skin compromise and
subsequent pain and infection. The goals of this program were to
develop and implement strategies to ensure early detection of
patients at risk for skin breakdown and to standardize the plan of
care. Many of the patients in our program are undergoing a bone
marrow/stem cell transplantation, radiation therapy, or standard
chemotherapy. Each unit within the the hospital designates a
“unit-based” skin care champion who is responsible for the over-
sight of patients and the education of staff.
The purpose of this abstract is to (1) educate the learner about
strategies for early detection and identiﬁcation of patients at high risk
for skin breakdown; (2) share with the learner the goals and objectives
of the Duke Skin Care Initiative; and (3) illustrate several initiatives
that have minimized the morbidity and mortality associated with skin
breakdown in the immunocmpromised pediatric patient. Outcome
data related to this program will be shared with the audience.
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Background. Enteral nutritional support in young children un-
dergoing HSCT is hampered by severe mucositis and nausea/
vomiting. Infants are occasionally being breast-fed at the time of
HSCT. A large literature on the beneﬁts of breast-feeding in
normal infants is available; however, there is no study of nutritional
support with maternal milk in infants undergoing HSCT and its
impact. Nutritional composition and other elements contains in
the maternal milk confers an advantage compared to prepared
formula. Also, maternal milk contains high titers of IgA. Maternal-
infant transmission of cytomegalovirus, West Nile virus, and other
viruses is, however, possible by breast-feeding. We report here our
experience in 4 babies who were breast-fed during their allogeneic
HSCT. Methods. Infants receiving breast milk were evaluated.
Maternal milk was obtained by direct breast-feeding. If mucositis/
nausea prevented good sucking, then maternal milk was obtained
from the mothers, frozen if necessary, and administered by bottle
or by feeding tube. In addition, parenteral nutritional (TPN)
support may have been given. Results. The infants were age 21
days to 11 months at time of HSCT. Diagnoses were acute my-
elogenous leukemia, Krabbe syndrome, leukocyte adhesion deﬁ-
ciency, and familial hemophagocytic syndrome. Patients received
HLA-matched related or unrelated transplantations. The prepar-
ative regimen consisted of BuCy  VP16, along with CSA/
MTX  ATG as GVHD prophylaxis. All 4 patients had to stop
maternal breast-feeding and were given maternal milk by nasoje-
junal feeding tube. Additional nutritional support with TPN was
required for 3 patients. Intravenous electrolytes additives were
adjusted according to blood studies done daily. Complications
during the transplantations were VOD (in 2 patients), septicemia
(in 2 patients), reactivation of CMV (in 1 patient), EBV (in 1),
postbiopsy duodenal hematoma (in 1), aGVHD (in 1), cGVHD (in
1), pseudomembranous colitis (in 1), and epiglottitis (in 1). All
babies engrafted and remain alive and well after an average of 35
months posttransplantation. Bacterial cultures were done on ma-
ternal milk in 2 cases at various times at room temperature and
postthawing. One culture grew Pseudomonas aeruginosa; the child
was colonized pretransplantation with the same bacteria that was
found positive on a throat culture. Conclusions. Breast-feeding is
feasible during HSCT. Appropriate antibacterial decontamination
and microbiological study of the mothers is needed to decrease
maternal-to-infant contamination.
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